Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen versus placebo for immediate effects during running in patellofemoral pain
ACTRN12626001161314Phase 4Not yet recruiting
- Sponsor
- La Trobe University
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in patellofemoral pain syndrome (PFPS) and Chronic knee pain comparing Ibuprofen with Placebo (2 arms). Primary endpoints: Knee pain intensity after running and Peak patellofemoral joint force during running. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ibuprofen
03
Conditions
patellofemoral pain syndrome (PFPS)Chronic knee pain
Beyond the preview
Go deeper on ACTRN12626001161314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626001161314.